These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25900515)

  • 1. Involvement of Concentrative Nucleoside Transporter 1 in Intestinal Absorption of Trifluridine Using Human Small Intestinal Epithelial Cells.
    Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
    J Pharm Sci; 2015 Sep; 104(9):3146-53. PubMed ID: 25900515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
    Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
    Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of concentrative nucleoside transporter 1 in intestinal absorption of trifluorothymidine, a novel antitumor nucleoside, in rats.
    Okayama T; Yoshisue K; Kuwata K; Komuro M; Ohta S; Nagayama S
    J Pharmacol Exp Ther; 2012 Feb; 340(2):457-62. PubMed ID: 22076553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
    Sakamoto K; Yokogawa T; Ueno H; Oguchi K; Kazuno H; Ishida K; Tanaka N; Osada A; Yamada Y; Okabe H; Matsuo K
    Int J Oncol; 2015; 46(6):2327-34. PubMed ID: 25901475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of observational studies of trifluridine/tipiracil (TAS-102) for metastatic colorectal cancer.
    Andersen SE; Andersen IB; Jensen BV; Pfeiffer P; Ota T; Larsen JS
    Acta Oncol; 2019 Aug; 58(8):1149-1157. PubMed ID: 31002008
    [No Abstract]   [Full Text] [Related]  

  • 7. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
    Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
    Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice.
    Persaud AK; Bernier MC; Massey MA; Agrawal S; Kaur T; Nayak D; Xie Z; Weadick B; Raj R; Hill K; Abbott N; Joshi A; Anabtawi N; Bryant C; Somogyi A; Cruz-Monserrate Z; Amari F; Coppola V; Sparreboom A; Baker SD; Unadkat JD; Phelps MA; Govindarajan R
    Nat Commun; 2023 Jun; 14(1):3175. PubMed ID: 37264059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.
    Yamamoto T; Kuniki K; Takekuma Y; Hirano T; Iseki K; Sugawara M
    Eur J Pharmacol; 2007 Feb; 557(1):1-8. PubMed ID: 17140564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional expression of human intestinal Na+-dependent and Na+-independent nucleoside transporters in Xenopus laevis oocytes.
    Chandrasena G; Giltay R; Patil SD; Bakken A; Unadkat JD
    Biochem Pharmacol; 1997 Jun; 53(12):1909-18. PubMed ID: 9256166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.
    Gray JH; Mangravite LM; Owen RP; Urban TJ; Chan W; Carlson EJ; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; Giacomini KM
    Mol Pharmacol; 2004 Mar; 65(3):512-9. PubMed ID: 14978229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.
    Fujimoto Y; Nakanishi R; Nukatsuka M; Matsuoka K; Ando K; Wakasa T; Kitao H; Oki E; Maehara Y; Mori M
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1029-1038. PubMed ID: 32322913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia coli nucleoside-H(+) cotransporter (NupC) produced in Xenopus laevis oocytes.
    Loewen SK; Yao SY; Slugoski MD; Mohabir NN; Turner RJ; Mackey JR; Weiner JH; Gallagher MP; Henderson PJ; Baldwin SA; Cass CE; Young JD
    Mol Membr Biol; 2004; 21(1):1-10. PubMed ID: 14668133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
    Tanaka N; Sakamoto K; Okabe H; Fujioka A; Yamamura K; Nakagawa F; Nagase H; Yokogawa T; Oguchi K; Ishida K; Osada A; Kazuno H; Yamada Y; Matsuo K
    Oncol Rep; 2014 Dec; 32(6):2319-26. PubMed ID: 25230742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides.
    Hiratochi M; Tatani K; Shimizu K; Kuramochi Y; Kikuchi N; Kamada N; Itoh F; Isaji M
    Eur J Pharmacol; 2012 Sep; 690(1-3):183-91. PubMed ID: 22709993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of intestinal absorption of mizoribine mediated by concentrative nucleoside transporters in rats.
    Mori N; Yokooji T; Kamio Y; Murakami T
    Eur J Pharmacol; 2008 May; 586(1-3):52-8. PubMed ID: 18371949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling.
    Pastor-Anglada M; Errasti-Murugarren E; Aymerich I; Casado FJ
    J Physiol Biochem; 2007 Mar; 63(1):97-110. PubMed ID: 17722647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside transporter expression and function in cultured mouse astrocytes.
    Peng L; Huang R; Yu AC; Fung KY; Rathbone MP; Hertz L
    Glia; 2005 Oct; 52(1):25-35. PubMed ID: 15892125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer.
    Masuishi T; Taniguchi H; Kawakami T; Kawamoto Y; Kadowaki S; Onozawa Y; Muranaka T; Tajika M; Yasui H; Nakatsumi H; Yuki S; Muro K; Omae K; Komatsu Y; Yamazaki K
    ESMO Open; 2019 Nov; 4(6):. PubMed ID: 32392174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.